Browse: Companies | People | Financial Organizations
Home > Financial Organizations > Versant Ventures

General Information

Websiteversantventures.com
Phone(650) 233-7877
Employees12
Founded1999
DescriptionVenture capital Firm

Funds

Versant Ventures, 8/08 $500M

Offices

Menlo Park, USA
3000 Sand Hill Road, Bldg 4
Suite 210
Menlo Park, CA, 94025
USA
Newport Beach, USA
450 Newport Center Drive
Suite 600
Newport Beach, CA, 92660
USA
San Francisco, USA
1700 Owens Street
Suite 541
San Francisco, CA, 94158
USA

People

Tags

Versant Ventures

Versant Ventures is a leading healthcare-focused venture capital firm specializing in early-stage investments in medical devices, biotechnology and pharmaceuticals, healthcare services, and healthcare information technology. The firm, founded in 1999, consists of a seasoned team of twelve managing directors with more than 130 years of venture capital investing experience and more than 150 years of operating experience.

Milestones

Investments

Company Date Round Size Participants
Fluidigm 11/09Unattributed$7.5M8
Metabolex 11/09Unattributed$8.6M12
Augmenix 10/09Series B$6.1M4
Flexion Therapeutics 10/09Series A$33M3
Rennovia 9/09Series A$12.3M2
Ocular Therapeutix 6/09Series C$15M3
Transcend Medical 6/09Series A$9.4M3
Anaphore 6/09Series A$13M5
Clovis Oncology 5/09Series A$145M7
RedBrick Health 4/09Series C$15M4
Ambrx 4/09Series D$10M7
LensX Lasers 3/09Series B$22.4M3
Synosia Therapeutics 1/09Series B$29M7
Cardiac Concepts 10/08Series B$21M6
APT Pharmaceuticals 9/08Series A$32M7
Microfabrica 9/08Series B$22.5M6
Glaukos 8/08Series D$35M7
Vaccsys 6/08Unattributed$9M3
Kythera Biopharmaceuticals 5/08Series C$30M9
NovaSys 5/08Unattributed$49.5M10
Anaphore 4/08Unattributed$8M2
Cameron Health 3/08Series E$14M4
Benvenue Medical 1/08Series B$15M3
Metabolex 4/07Series D$32M16
Fluidigm 1/07Series E$17M10
Synosia Therapeutics 1/07Unattributed$32.5M4
NeoVista 12/06Series C$41M6
Impedance Cardiology Systems 11/06Series B$5M2
NeoVista 9/06Series B$26M4

Videos

Sources

  1. Versant Ventures raises $500M for life sciences investing (deals.venturebeat.com) [edit]
  2. Fluidigm raises another $7.5M for stem-cell analysis chips (venturebeat.com) [edit]
  3. Metabolex (Metabolex.com) [edit]
  4. Xconomy Boston (xconomy.com) [edit]
  5. Flexion garners $33M in Series A (fiercebiotech.com) [edit]
  6. Rennovia Grabs $12M for Renewable Chemicals (earth2tech.com) [edit]
  7. I-Therapeutix, Inc.: Series C $15M (onbiovc.com) [edit]
  8. Transcend Medical sees $20M for glaucoma device (deals.venturebeat.com) [edit]
  9. Anaphore, Inc.: Series A $13M (onbiovc.com) [edit]
  10. Clovis Oncology (Boulder, CO) an entity focused on licensing or acquiring rights to oncology compounds in all stages of clinical development (onbiovc.com) [edit]
  11. CVCA (cvca.com.cn) [edit]
  12. Ambrx, Inc.: Series D $10M (onbiovc.com) [edit]
  13. LensX Lasers nabs $22M for eye surgery lasers (venturebeat.com) [edit]
  14. Synosia raises $29M for Phase II testing (fiercebiotech.com) [edit]
  15. Cardiac Concepts Raises $21 Million (equityhelpdesk.com) [edit]
  16. APT Pharmaceuticals Secures $32 Million in Series B Financing (aptbio.com) [edit]
  17. Microfabrica Secures $22.5 Million Funding to Grow its Medical Device Business (microfabrica.com) [edit]
  18. Glaukos Adds $35 Million (equityhelpdesk.com) [edit]
  19. Vaccsys raises $9 million for vaccine research (deals.venturebeat.com) [edit]
  20. Capital Funding Report [edit]
  21. Novasys Medical takes $49.5M for women’s medical device (deals.venturebeat.com) [edit]
  22. April 15, 2008 - Anaphore Receives $8M In Financing (anaphoreinc.com) [edit]
  23. Defibrillator maker Cameron Health takes in $14M (deals.venturebeat.com) [edit]
  24. Benvenue Medical Closes $15 Million Series B Financing (benvenuemedical.com) [edit]
  25. Metabolex (Metabolex.com) [edit]
  26. Life science fluid control company, Fluidigm, raises $17M more (deals.venturebeat.com) [edit]
  27. Neurological co. Synosis raises $32.5M (deals.venturebeat.com) [edit]
  28. NeoVista, a co. targeting age-related macular degeneration, raises $41M (deals.venturebeat.com) [edit]
  29. Impedance Cardiology raises $5 million (deals.venturebeat.com) [edit]
  30. NeoVista, a radiation treatment device maker, to raise $26M (deals.venturebeat.com) [edit]
Edit This Page
Last Edited 11/20/09

Revision History RSS Picture

External Links

Embed Widget

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy